Advertisement
U.S. Markets closed

XBiotech Inc. (4XB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
6.55+0.05 (+0.77%)
At close: 08:09AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 204.59M
Enterprise Value 38.98M
Trailing P/E 1.28
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.67
Price/Book (mrq)1.09
Enterprise Value/Revenue -64.61
Enterprise Value/EBITDA -1.49

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.05
52 Week Low 33.14
50-Day Moving Average 36.13
200-Day Moving Average 36.16

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 530.46M
Implied Shares Outstanding 6N/A
Float 819.83M
% Held by Insiders 135.13%
% Held by Institutions 115.09%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 15, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.90%
Return on Equity (ttm)-16.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -41.19M
Net Income Avi to Common (ttm)-35.01M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.53M
Total Cash Per Share (mrq)6.19
Total Debt (mrq)10M
Total Debt/Equity (mrq)5.08
Current Ratio (mrq)11.13
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-23.5M
Levered Free Cash Flow (ttm)-18.41M